Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-26-222953
Filing Date
2026-05-14
Accepted
2026-05-14 09:03:51
Documents
1
Effectiveness Date
2026-05-14

Document Format Files

Seq Description Document Type Size
1 S-8 POS d21842ds8pos.htm S-8 POS 30515
  Complete submission text file 0001193125-26-222953.txt   31527
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-229876 | Film No.: 26976127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)